Latest / Oncology Data Advisor
The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF
In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque sits down with Luis Valente, CEO and Co-Founder of iLoF, a digital health company pioneering a breakthrough AI platform to accelerate the future of personalized drug discovery and development.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.